Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.5%Capital Expenditures Margin
VS
Market
Sector
Industry
History
$ 4.55Close
$ 2.88 - $ 4.9 52-Week Range
Ticker Information
Ticker
ABUSCompany Name
ARBUTUS BIOPHARMA CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQARBUTUS BIOPHARMA CORP - Capital Expenditures Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ABUS - CapEx % Historical data
| Date | Capital Expenditure | Capital Expenditures Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 77K | 0.5% | $ 15.42M |
| 3/31/2025 | $ 87K | 1.36% | $ 6.4M |
| 12/31/2024 | $ 182K | 2.95% | $ 6.17M |
| 9/30/2024 | $ 96K | 1.42% | $ 6.74M |
| 6/30/2024 | $ 108K | 1.07% | $ 10.06M |
| 3/31/2024 | $ 966K | 7.44% | $ 12.99M |
| 12/31/2023 | $ 988K | 5.45% | $ 18.14M |
| 9/30/2023 | $ 1.14M | 5.13% | $ 22.24M |
| 6/30/2023 | $ 1.22M | 5.19% | $ 23.54M |
| 3/31/2023 | $ 554K | 1.67% | $ 33.13M |
Key Performance Insights, Last 5 Years
- ARBUTUS BIOPHARMA CORP's latest trailing twelve months (TTM) CapEx % stands at 2.28%.
- Over the past 5 years, ARBUTUS BIOPHARMA CORP's average CapEx % has been 3.81%.
- The median CapEx % for ARBUTUS BIOPHARMA CORP during this period was 3.13%
- ARBUTUS BIOPHARMA CORP reached its highest CapEx % over the past 5 years at 10.71%.
- The lowest CapEx % recorded by ARBUTUS BIOPHARMA CORP in the same timeframe 0.5%
ARBUTUS BIOPHARMA CORP's CapEx % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx % Benchmarks
Similar metrics to Revenues:
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
Definition of Capital Expenditures Margin
[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].CapEx / Revenues
(=) CapEx % CapEx % for ARBUTUS BIOPHARMA CORP is calculated as follows: CapEx [ $ 140K ] / Revenues [ $ 6.15M ]
(=) CapEx % [ 2.28% ] ABUS - Capital Expenditures Margin, Last 5 years
0.5%
Minimum
Jun 30, 2025
10.71%
Maximum
Jun 30, 2021
3.81%
Average
3.13%
Median
CapEx % Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.46% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
| filtered constituents | 2.85K |
|---|---|
| min | 0% |
| max | 15.04% |
| average | 3.46% |
| median | 2.43% |
| std | 3.27% |